Inner Mongolia Mengyao Pharmaceutical

Inner Mongolia Mengyao Pharmaceutical Co., Ltd., headquartered in Tongliao, Inner Mongolia, is a leading Chinese pharmaceutical company specializing in Traditional Mongolian Medicine (TMM). Established in 2000 following the restructuring of a state-owned factory from the 1980s, the company integrates research, GAP-certified herbal cultivation, manufacturing, and global distribution. Its extensive product portfolio includes over 100 varieties of medicines, with flagship products such as the Areca Thirteen Pill (GY-13) and Zhenbao Pill, targeting neurological, cardiovascular, and chronic inflammatory conditions. The company is at the forefront of modernizing ethnic medicine, employing network pharmacology and clinical research to validate the efficacy of traditional formulas for modern therapeutic needs, such as major depressive disorder and stroke recovery.